Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051).
      QxMD      Google Scholar   
Citation:
Ann Oncol vol 25 (5) 1039-44
Year:
2014
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
934 is parent abstract
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
3
Parents:
934   972  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U10 CA180821, U10 CA180882  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
ACOSOG-Z4051
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
chemotherapy, epidermal growth factor receptor, esophageal cancer, esophagectomy, neoadjuvant therapy, radiation therapy